Aside from breast cancer, varying degrees of mammaglobin-A presence have been documented in cancers like uterine endometrium carcinomas, ovarian carcinomas, and prostatic adenocarcinomas [8]. This evidence concerns the gene SCGB2A2 and breast carcinoma.